Invesco’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Buy |
43,395
+10,129
| +30% | +$135K | ﹤0.01% | 3098 |
|
|
2025
Q1 | $339K | Buy |
33,266
+20,650
| +164% | +$210K | ﹤0.01% | 3298 |
|
|
2024
Q4 | $200K | Buy |
12,616
+453
| +4% | +$7.17K | ﹤0.01% | 3501 |
|
|
2024
Q3 | $706K | Buy |
12,163
+298
| +3% | +$17.3K | ﹤0.01% | 3062 |
|
|
2024
Q2 | $542K | Sell |
11,865
-76,818
| -87% | -$3.51M | ﹤0.01% | 3232 |
|
|
2024
Q1 | $5.87M | Buy |
88,683
+78,703
| +789% | +$5.21M | ﹤0.01% | 2120 |
|
|
2023
Q4 | $397K | Sell |
9,980
-6,571
| -40% | -$261K | ﹤0.01% | 3320 |
|
|
2023
Q3 | $528K | Buy |
16,551
+5,409
| +49% | +$172K | ﹤0.01% | 3160 |
|
|
2023
Q2 | $448K | Buy |
11,142
+700
| +7% | +$28.1K | ﹤0.01% | 3280 |
|
|
2023
Q1 | $446K | Buy |
10,442
+2,615
| +33% | +$112K | ﹤0.01% | 3307 |
|
|
2022
Q4 | $376K | Sell |
7,827
-229
| -3% | -$11K | ﹤0.01% | 3392 |
|
|
2022
Q3 | $303K | Buy |
+8,056
| New | +$303K | ﹤0.01% | 3488 |
|
|
2022
Q2 | – | Sell |
-6,980
| Closed | -$379K | – | 4059 |
|
|
2022
Q1 | $379K | Buy |
6,980
+43
| +0.6% | +$2.34K | ﹤0.01% | 3500 |
|
|
2021
Q4 | $406K | Sell |
6,937
-690
| -9% | -$40.4K | ﹤0.01% | 3441 |
|
|
2021
Q3 | $301K | Sell |
7,627
-67,877
| -90% | -$2.68M | ﹤0.01% | 3623 |
|
|
2021
Q2 | $3.21M | Sell |
75,504
-115,919
| -61% | -$4.92M | ﹤0.01% | 2633 |
|
|
2021
Q1 | $11.8M | Buy |
191,423
+1,704
| +0.9% | +$105K | ﹤0.01% | 1861 |
|
|
2020
Q4 | $13.4M | Buy |
189,719
+1,637
| +0.9% | +$115K | ﹤0.01% | 1657 |
|
|
2020
Q3 | $7.25M | Sell |
188,082
-113,743
| -38% | -$4.39M | ﹤0.01% | 1813 |
|
|
2020
Q2 | $11.3M | Buy |
+301,825
| New | +$11.3M | ﹤0.01% | 1570 |
|